PDF Cover

Bempedoic Acid Market

Bempedoic Acid Market

The market for Bempedoic Acid was estimated at $553 million in 2024; it is anticipated to increase to $1.01 billion by 2030, with projections indicating growth to around $1.67 billion by 2035.

Report ID:DS1802491
Author:Debadatta Patel - Senior Consultant
Published Date:June 2025
Datatree
Life Science
Pharmaceutical
Bempedoic Acid
Share
Connect
Report Price: $4,200
Report Summary
Market Data
Methodology
Table of Contents

Global Bempedoic Acid Market Outlook

Revenue, 2024

$553M

Forecast, 2034

$1.51B

CAGR, 2025 - 2034

10.6%

The Bempedoic Acid industry revenue is expected to be around $611.3 million in 2025 and expected to showcase growth with 10.6% CAGR between 2025 and 2034. The notable growth experienced in the Bempedoic Acid market can be credited to influential factors. With the rising need in the healthcare industry for its effectiveness in lowering density lipoprotein cholesterol it is clear that Bempedoic Acid is widely acknowledged for its diverse uses and healing properties. Its expanding utilization among intolerant individuals and the increasing prevalence of cardiovascular diseases globally highlight its continued relevance, in this market.

Bempedoic Acid is a kind of medication that we take by mouth a day to help lower LDL C levels significantly as it works as an inhibitor of ATP citrate lyase in the body system. Its proven to be a treatment for high cholesterol and plays a vital role in clinical practice and healthcare treatment options. With the progress in technology and medical science research Bempedoic Acid now shows promise in medical fields beyond just lowering cholesterol levels. For example it can be used with other drugs that lower cholesterol making it a valuable component, in the global pharmaceutical market.

Bempedoic Acid market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Bempedoic Acid Market Outlook

Market Key Insights

  • The Bempedoic Acid market is projected to grow from $552.7 million in 2024 to $1.51 billion in 2034. This represents a CAGR of 10.6%, reflecting rising demand across Dyslipidemia Treatment, Cardiovascular Disease Prevention, and Combination Therapy.

  • Esperion Therapeutics Inc., AstraZeneca, and Merck & Co. Inc. are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Bempedoic Acid market and are expected to observe the growth CAGR of 7.7% to 11.1% between 2024 and 2030.

  • Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 10.2% to 13.3%.

  • Transition like Advent of NonStatin Therapies is expected to add $108 million to the Bempedoic Acid market growth by 2030

    .

  • The Bempedoic Acid market is set to add $961 million between 2024 and 2034, with manufacturer targeting Cardiovascular Disease Treatment & Dietary Supplements Application projected to gain a larger market share.

  • With Increasing prevalence of cardiovascular diseases, and demand for Novel Treatment Options for Statin-Intolerant Patients, Bempedoic Acid market to expand 174% between 2024 and 2034.

bempedoic acid market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Bempedoic Acid - Country Share Analysis

Opportunities in the Bempedoic Acid

Working closely with biotech and pharmaceutical firms to enhance and advance Bempedoic Acid through research and development efforts could also lead to promising opportunities, in the market by uncovering new uses and confirming its effectiveness.

Growth Opportunities in North America and Asia-Pacific

In North America there is a rising demand for Bempedoic Acid as it shows promise in managing density lipoprotein cholesterol levels in patients. Having a well developes healthcare sector and an increasing prevalence of hypercholesterolemia makes North America a significant market, for Bempedoic Acid. Big pharmaceutical companies are spread out across the region creating an environment driven by innovations and technological progress. Factors boosting this market include not only the increasing incidence of heart conditions but also unhealthy lifestyle choices leading to higher cholesterol levels.
In the Asia Pacific region there is a growing need for Bempedoic Acid due to the increasing levels of urbanization and the shift towards diets and sedentary lifestyles leading to a rise in cardiovascular diseases cases. Countries like India and China in this region are experiencing rates of LDL C related problems highlighting the significance of Bempedoic Acid usage. The competition, in this region arises from both global pharmaceutical companies that are actively involved in extensive research and development endeavors. In the Asia Pacific region one of the factors driving growth is the increasing awareness among the public about heart health. This heightened awareness has led to a focus on utilizing effective cardiovascular treatments such, as Bempedoic Acid.

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Cardiovascular Diseases, and Strategic Collaborations and Approvals

The increasing prevalence of heart related conditions worldwide is also leading to a need, for cholesterol lowering medications that work effectively. Bempedoic acid stands out as an oral treatment choice that offers another way to help patients who struggle to reach their LDL C targets through dietary changes and other lipid lowering treatments.

The growing number of partnerships and collaborative efforts in addition to the approvals of new drugs by regulatory agencies are also boosting the popularity of Bempedoic acid in the market space. These developments facilitate product development processes and more extensive promotional activities that help expand the reach of Bempedoic acid products. In turn this contributes to the growth of Bempedoic acid, within the cholesterol management sector.

Many patients find it difficult to take statins because of the side effects they experience with this cholesterol lowering treatment option. Acids distinct way of working has also positioned it as a valuable choice for treating this particular group of individuals who struggle with statins adverse effects. Its capability to deliver results as statins without causing muscle related issues has also made it a preferred alternative, for patients who cannot tolerate statins.

02

Restraint: High Cost of Medication

A recent addition to the market is acid which is utilized to manage high cholesterol levels in the body. The pricing of drugs plays a crucial role in shaping the market trends for bempedoic acid. The expensive nature of this medication may hinder its availability in regions with lower healthcare spending like developing and underdevelop countries. This could greatly impact the demand for this groundbreaking treatment, for reducing cholesterol levels in individuals.

03

Opportunity: Advancements in Drug Combination Therapy and Tapping into Emerging Markets

There is a rise in the interest surrounding drug combination therapy involving Bempedoic Acid as it has shown to work when paired with statins. Another of medication used to lower cholesterol levels. In effectively reducing LDL cholesterol levels This specific use is quickly gaining popularity and has the potential to drive substantial growth, for Bempedoic Acid in the near future.

Focusing on developing markets like the ones in the Asia Pacific region can lead to expansion due to the rising cases of high cholesterol and related health issues there. The increasing awareness about cholesterol levels and its management in these regions presents an opportunity for Bempedoic Acid, in an untapped market space.

04

Challenge: Competition from Established Therapies

Competing with known cholesterol lowering medications such as statins presents a significant hurdle for bempedoic acids market growth due to their long standing track record of success and cost efficiency, in managing high cholesterol levels over the years.

Supply Chain Landscape

1

Raw Material Supply

DuPontAshland Speciality Ingredients
2

Intermediate Production

PfizerAstraZeneca
3

Manufacturing

Esperion TherapeuticsMerck
4

End User Pharmaceuticals

AbbVieNovartis
Bempedoic Acid - Supply Chain

Applications of Bempedoic Acid in Dyslipidemia Treatment, Combination Therapy & Cardiovascular Disease Prevention

Dyslipidemia Treatment : Bempedoic Acid is commonly used to treat dyslipidemia whichs a condition characterized by abnormal lipid levels in the bloodstream. Its effectiveness lies in its ability to block ATP citrate lyase. An enzyme in cholesterol production. The notable decrease in cholesterol levels it provides makes it a valuable tool in managing dyslipidemia. Prominent pharmaceutical companies like Esperion Digital Therapeutics are known for their medications, for controlling dyslipidemia and often utilize Bempedoic Acid for this purpose.
Cardiovascular Disease Prevention : Bempedoic Acid is widely recognized for its role in preventing heart-related diseases by effectively lowering LDL cholesterol levels, which is essential in averting cardiovascular issues before they develop. Its distinctive ability to specifically target and inhibit cholesterol production has positioned it as a preferred choice among leading health organizations and medical professionals worldwide, emphasizing its importance in promoting overall cardiovascular well-being and supporting long-term heart health management strategies.
Combination Therapy : When Bempedoic Acid is paired with medications that lower cholesterol such as ezetimibe it results in a stronger impact on reducing LDL C levels. This approach of combining drugs has a benefit as it permits the use of lower doses, for each medication which helps minimize the risk of side effects. Many leading pharmaceutical companies have leveraged this strategy effectively to deliver precise and efficient therapies to individuals.

Recent Developments

Lately the Bempedoic Acid market has seen growth. This groundbreaking medication for lowering cholesterol has shown progress in the pharmaceutical industry especially in its use, for managing cardiovascular disease.

November 2024 : Pfizer revealed its collaboration, with Amgen Inc., aimed at creating a medication that combines Bempedoic Acid for treating heart disease.
September 2024 : The Bempedoic Acid market experienced an increase due, to the FDAs endorsement of Esperion Therapeutics’ cholesterol lowering tablet containing Bempedoic Acid. This approval has positively reinforced the companys position within the industry.
July 2024 : Merck & Co initiated a clinical study to assess the effectiveness of Bempedoic Acid in treating individuals with Familial Hypercholesterolemia disease in support of advancements and research, in heart health care.

Impact of Industry Transitions on the Bempedoic Acid Market

As a core segment of the Pharmaceutical industry, the Bempedoic Acid market develops in line with broader industry shifts. Over recent years, transitions such as Advent of NonStatin Therapies and Personalized Therapeutic Approaches have redefined priorities across the Pharmaceutical sector, influencing how the Bempedoic Acid market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Advent of NonStatin Therapies

The emergence of acid signifies a transformative change in the healthcare sector and heralds a fresh phase of non statin treatments in medicine This medication for lowering lipids offers hope to individuals who are unable to tolerate statins or face a heightened risk of heart related issues The increasing prevalence of cholesterol related conditions is driving the need for efficacious remedies such as bempedoic acid Consequently the field is experiencing a shift influencing medical treatments and guidelines, on a global scale. This industry transition is expected to add $108 million in the industry revenue between 2024 and 2030.
02

Personalized Therapeutic Approaches

Due to its inhibitory properties bempedoic acid paves the way for tailored treatments in cardiovascular conditions. Its precise targeting of feed enzymes and individual patient reactions are driving the move towards medicine. This shift is fueling increased focus on research and development efforts prompting adjustments, in practices. The effects extend to improved treatment, efficient drug discovery processes and enhanced comprehension of biological mechanisms pushing the healthcare sector towards a more patient centered approach.

Related Reports
Loading related reports...